Overview

Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study is an observational safety surveillance study designed to prospectively assess patients with high-grade osteosarcoma who are candidates for treatment with mifamurtide within the context of prevailing standard oncology practice
Details
Lead Sponsor:
Millennium Pharmaceuticals, Inc.
Treatments:
Mifamurtide